abstract |
The present invention relates to cyclopropylamines as lysine-specific demethylase 1 (LSD1) inhibitors and their application in the manufacture of medicaments for the treatment of LSD1-related diseases. Specifically, it relates to a compound represented by the formula (I) and a pharmaceutically acceptable salt thereof. Embedded image |